These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1280738)

  • 1. Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
    Bowersox SS; Singh T; Nadasdi L; Zukowska-Grojec Z; Valentino K; Hoffman BB
    J Cardiovasc Pharmacol; 1992; 20(5):756-64. PubMed ID: 1280738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays.
    Wright CE; Robertson AD; Whorlow SL; Angus JA
    Br J Pharmacol; 2000 Dec; 131(7):1325-36. PubMed ID: 11090104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    Bowersox SS; Miljanich GP; Sugiura Y; Li C; Nadasdi L; Hoffman BB; Ramachandran J; Ko CP
    J Pharmacol Exp Ther; 1995 Apr; 273(1):248-56. PubMed ID: 7714772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.
    Gaur S; Newcomb R; Rivnay B; Bell JR; Yamashiro D; Ramachandran J; Miljanich GP
    Neuropharmacology; 1994 Oct; 33(10):1211-9. PubMed ID: 7862257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels.
    Kristipati R; Nádasdi L; Tarczy-Hornoch K; Lau K; Miljanich GP; Ramachandran J; Bell JR
    Mol Cell Neurosci; 1994 Jun; 5(3):219-28. PubMed ID: 8087420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers.
    Wang YX; Bezprozvannaya S; Bowersox SS; Nadasdi L; Miljanich G; Mezo G; Silva D; Tarczy-Hornoch K; Luther RR
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):159-68. PubMed ID: 9521489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel omega-conopeptides reduced field potential amplitudes in the rat hippocampal slice.
    Fox JA
    Neurosci Lett; 1994 Jan; 165(1-2):157-60. PubMed ID: 8015718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated autonomic and behavioral responses to L/N Ca2(+)-channel blocker omega-conotoxin in conscious rats.
    Shapira S; Adeyemo OM; Feuerstein G
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R427-38. PubMed ID: 1697739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for omega-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA).
    Woppmann A; Ramachandran J; Miljanich GP
    Mol Cell Neurosci; 1994 Aug; 5(4):350-7. PubMed ID: 7804605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC omega-conopeptides.
    Fox JA
    Pflugers Arch; 1995 Apr; 429(6):873-5. PubMed ID: 7603842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally injected histamine increases posterior hypothalamic acetylcholine release in hemorrhage-hypotensive rats.
    Altinbas B; Yilmaz MS; Savci V; Jochem J; Yalcin M
    Auton Neurosci; 2015 Jan; 187():63-9. PubMed ID: 25468497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
    Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats.
    Malmberg AB; Yaksh TL
    Pain; 1995 Jan; 60(1):83-90. PubMed ID: 7715945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent vascular to cardiac sympatholytic selectivity of omega-conotoxin GVIA in the pithed rat.
    Pruneau D; Angus JA
    Eur J Pharmacol; 1990 Aug; 184(1):127-33. PubMed ID: 2209709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury.
    Samii A; Badie H; Fu K; Luther RR; Hovda DA
    J Neurotrauma; 1999 Oct; 16(10):879-92. PubMed ID: 10547097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeys.
    Bowersox S; Mandema J; Tarczy-Hornoch K; Miljanich G; Luther RR
    Drug Metab Dispos; 1997 Mar; 25(3):379-83. PubMed ID: 9172958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.
    Xiao WH; Bennett GJ
    J Pharmacol Exp Ther; 1995 Aug; 274(2):666-72. PubMed ID: 7636726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans.
    McGuire D; Bowersox S; Fellmann JD; Luther RR
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):400-3. PubMed ID: 9300326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.